A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4619904)

Published in Comput Math Methods Med on October 11, 2015

Authors

Yueping Zhan1, Wenna Guo1, Ying Zhang2, Qiang Wang3, Xin-jian Xu4, Liucun Zhu1

Author Affiliations

1: School of Life Sciences, Shanghai University, Shanghai 200444, China.
2: Yangzhou Breeding Biological Agriculture Technology Co. Ltd., Yangzhou 225200, China.
3: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.
4: Department of Mathematics, Shanghai University, Shanghai 200444, China.

Articles cited by this

Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38

Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72

Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60

Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics (2000) 10.63

Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes Cancer (2010) 3.78

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol (2013) 3.68

Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med (2005) 2.56

Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol (2011) 2.55

Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. Sci Transl Med (2013) 2.34

Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling. Cell (2014) 2.12

ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet (2012) 1.93

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan. Nat Genet (2012) 1.90

Consistency of Random Survival Forests. Stat Probab Lett (2010) 1.29

Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method. Mol Cell Proteomics (2008) 1.28

A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res (2014) 1.27

Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers. Eur Urol (2014) 1.21

Evolving therapeutic targets in renal cell carcinoma. Curr Opin Oncol (2013) 1.08

Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers. Genes Chromosomes Cancer (2012) 1.06

Mammalian iron transporters: families SLC11 and SLC40. Mol Aspects Med (2013) 0.96

p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol (2007) 0.90

Focused microarray analysis of glyco-gene expression in human glioblastomas. J Neurochem (2007) 0.90

A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. J Cancer Res Clin Oncol (2015) 0.90

PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis. PLoS One (2015) 0.88

Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk. PLoS One (2015) 0.88

Expression of cytoskeleton-associated protein 4 is related to lymphatic metastasis and indicates prognosis of intrahepatic cholangiocarcinoma patients after surgery resection. Cancer Lett (2013) 0.87

Characterization of the lipid binding properties of Otoferlin reveals specific interactions between PI(4,5)P2 and the C2C and C2F domains. Biochemistry (2014) 0.87

Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma. Urol Oncol (2015) 0.86

Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance. Mol Cell Biochem (2013) 0.85

Prediction models and risk assessment for silicosis using a retrospective cohort study among workers exposed to silica in China. Sci Rep (2015) 0.85

Evidence for genotype-phenotype correlation for OTOF mutations. Int J Pediatr Otorhinolaryngol (2014) 0.83

Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma. RNA (2015) 0.83

Biomarkers in renal cancer. Virchows Arch (2014) 0.82

The complex roles of microRNAs in the metastasis of renal cell carcinoma. J Nanosci Nanotechnol (2013) 0.82

High expression of pituitary tumor-transforming gene-1 predicts poor prognosis in clear cell renal cell carcinoma. Mol Clin Oncol (2014) 0.81

Transcriptome-wide signatures of tumor stage in kidney renal clear cell carcinoma: connecting copy number variation, methylation and transcription factor activity. Genome Med (2014) 0.81

Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma. Hum Pathol (2014) 0.80

Toward predicting metastatic progression of melanoma based on gene expression data. Pigment Cell Melanoma Res (2015) 0.77

Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma. Target Oncol (2014) 0.77

[Reduced expression of Diceri is associated with poor prognosis in patients with nasopharyngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2015) 0.77

A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro. Am J Hematol (2014) 0.77